FindTrial
Sign In

Observational study on newly diagnosed type 2 Diabetes patients in India

A cross-sectional (baseline) & observational real world study on newly diagnosed patients with type 2 diabetes in India - IDS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/026076
Enrollment
13000
Registered
2020-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Sponsors

Eris Lifesciences Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients (Aged 18 Years or above) who were newly diagnosed with type 2 diabetes and referred to the clinic within 1 year of diagnosis. 2. Diagnosis of diabetes will be based on American Diabetes Association criteria.

Exclusion criteria

Exclusion criteria: 1. Monogenic diabetes syndrome 2. Disease of the exocrine pancreas 3. Gestational Diabetes 4. Acute or severe chronic heart disease 5. Renal or psychiatric disease. 6. Initial evaluation in clinic after 1 year of diagnosis or unclear at time of diagnosis, type 1, type 1.5, or type 3 diabetes

Design outcomes

Primary

MeasureTime frame
To characterise/type/profile the newly diagnosed Indian patient with type 2 diabetes from the demographic details and laboratory investigationsTimepoint: 1 Year—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactBaishali Nath

Eris Lifesciences Ltd.

baishali.nath@erislifesciences.com8849494208

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026